SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion
about
Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusionIntravitreal steroids versus observation for macular edema secondary to central retinal vein occlusionA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal VeinBaseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.Management of macular edema secondary to branch retinal vein occlusion: an evidence-based update.Drug treatment of macular oedema secondary to central retinal vein occlusion: a network meta-analysis.Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.Correlation between spectral domain optical coherence tomography findings and visual outcomes in central retinal vein occlusion.Fundus changes in central retinal vein occlusion.Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis)Branch retinal vein occlusion: treatment modalities: an update of the literature.A meta-analysis of anti-vascular endothelial growth factor remedy for macular edema secondary to central retinal vein occlusionSCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusionComparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion.Intravitreal bevacizumab alone or combined with macular laser photocoagulation for recurrent or persistent macular edema secondary to branch retinal vein occlusion.Fundus changes in branch retinal vein occlusionCentral retinal vein occlusion: modifying current treatment protocols.Importance of Central Retinal Sensitivity for Prediction of Visual Acuity after Intravitreal Bevacizumb in Eyes with Macular Edema Associated with Branch Retinal Vein Occlusion.Treatments for macular oedema following central retinal vein occlusion: systematic review.Management of retinal vein occlusion--consensus document.Score Study Report 12: Development of venous collaterals in the Score Study.Predicting visual outcomes for macular disease using optical coherence tomography.Association of outer retinal layer morphology with visual acuity in patients with retinal vein occlusion: SCORE Study Report 13.Relationship between grades of macular perfusion and foveal thickness in branch retinal vein occlusion.Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
P2860
Q24187275-58D0414B-8DFA-41D7-BF0A-9995816D3F45Q24240914-53813210-A070-4EFC-B1B9-52B5EC2FED2EQ24646760-77A75519-80C8-4D9E-A2DD-34918DE2A765Q33711660-B0CBE748-9F2B-4A16-8995-3F5D92855151Q33770558-DEAC1BA7-4243-4FC0-BBEC-2720BF19EB43Q33995887-23A34432-5676-492E-9466-57D7CD418897Q34701929-A7FE1602-D8BE-4DC1-A1A4-38686DC5E293Q34702859-3AAA2FFA-A2EE-441F-9F64-9B3F195F07FEQ34729100-CF8CAF78-D0C5-4E97-ADBF-C138D70C62C3Q34772371-96BBB9AD-F745-42FD-9055-EEB1986C338AQ35016867-0B5C6803-DA3E-4F82-86AF-28D23DF81695Q35028773-87ED4C14-ACF3-424E-86C4-543E8735E690Q35077598-60481C1D-BC3F-447D-9DD4-84368CAF215BQ35085700-30D16FDA-8D8A-4A68-BE3A-6BDF7C5B5144Q35094088-5C5C24EA-5856-480E-A906-0BC45F74B407Q35098562-626F5EE2-B62A-4700-8A5C-9757C6D74F6BQ35223263-AD1651EF-4C58-4F6F-8F6C-F92EB9BA64D4Q35533268-7E3BBA0E-5D4A-4B31-9398-A365D686457EQ35921621-2EA3665D-0A67-4ACD-9F40-9BCE846F7C43Q35925907-71E62C29-5DFF-45DF-9482-30FEFFDB8BE7Q37590692-915A4405-0DD6-4E40-A84F-1ABB07E38C87Q37876127-DF3B5492-28E3-413F-8820-4279F2B93706Q38042851-5E00A18D-2260-4DA1-A1F2-650220A83A72Q38130239-335CFD34-102E-4D2E-BA6B-77FD33076335Q41895064-64FEC77B-051C-42DD-8AAD-7DE04B920119Q41948477-EE463D0F-CBE3-421D-9EE6-E174A5B23008Q47132309-B3B1ACA8-4088-4B1B-8481-3A8530F54002Q51354430-363F80AC-E751-4A74-8F60-9B2E6B78968F
P2860
SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
SCORE Study report 1: baseline ...... ts with retinal vein occlusion
@ast
SCORE Study report 1: baseline ...... ts with retinal vein occlusion
@en
type
label
SCORE Study report 1: baseline ...... ts with retinal vein occlusion
@ast
SCORE Study report 1: baseline ...... ts with retinal vein occlusion
@en
prefLabel
SCORE Study report 1: baseline ...... ts with retinal vein occlusion
@ast
SCORE Study report 1: baseline ...... ts with retinal vein occlusion
@en
P2093
P2860
P1433
P1476
SCORE Study report 1: baseline ...... ts with retinal vein occlusion
@en
P2093
Barbara A Blodi
Ingrid U Scott
J Michael Jumper
Maria Figueroa
Michael S Ip
Neal L Oden
Paul C VanVeldhuisen
SCORE Study Investigator Group
P2860
P304
P356
10.1016/J.OPHTHA.2008.10.017
P577
2009-01-22T00:00:00Z